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Substance Use Disorder (SUD) remains a critical issue in rural and tribal populations of Utah. 
In response, we created a consortium of recovery programs, tribal partners, social scientists, 
substance use disorders counselors, and treatment specialists to target prevention, treatment and 




Substance Use Disorder (SUD) is a persistent problem in Tooele County, Utah. Tooele county’s 
drug overdose death rate between 2015 and 2019 was 21 per 100,000 people, which is higher the 
statewide rate of approximately 20 per 100,000 people (Centers for Disease Control and 
Prevention, 2020). In addition to high fatal and non-fatal overdose rates, Tooele County lacks a 
adequately specialized trained workforce necessary for meeting SUD treatment needs and 
recovery support services to reduce harms associated with opioid use disorder (OUD) and other 
substance use issues (DasGupta, et al., 2020; Canary et al., 2017). To address these challenges, 
USU Extension received funding from the Health Resources and Services Administration 
(HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award 
totaling $1,000,000, and initiated a consortium between state, country and local partners to 
implement prevention, treatment and recovery activities.  
 
The selected strategies were adopted based on a review of effective interventions for addressing 
substance use. For example, individuals who are trained on how to use naloxone are more likely 
to know how to reduce their risk of overdose, and are less likely to die from an overdose 
(Katzman et al., 2018; Seal et al., 2001; Tobin et al., 2005; Walley et al., 2013). There is a 96% 
opioid overdose survival rate during layperson naloxone administration (Bennett et al., 2011).  
Stigma around opioid overdoses negatively affects the mental health of individuals who use 
drugs (Hatzenbuehler et al., 2013), and stigma reduction has been shown to facilitate treatment 
adherence and recovery (Versfeld, et al., 2020). Geographic areas with fewer providers offering 
medication treatment for opioid use disorder (MOUD) also have higher rates of overdose deaths 




With grant funding from the HHS, we designed a culturally responsive and multi-pronged 
community approach to tackle SUD in Tooele county. We focused on stigma reduction (i.e., 
community awareness campaigns and harm reduction trainings for professionals), expanded 
SUD work-force capacity (i.e., para-professional certifications and funding), and increased 
community-level support for persons in recovery (i.e., shared community events, economic aid, 
and naloxone distribution).  
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Target Populations 
 
The multi-pronged approach served several target populations. Community members and 
professionals impacted by stigma received substance use education and harm reduction trainings. 
Individuals in recovery with insufficient support received access to emergency recovery financial 
aid for treatment costs, transportation, childcare, and housing expenses. Agencies with an 
inadequate workforce received access to coalition resources, professional development support, 
and para-professional workforce funding.  
 
Program Outcomes and Impacts 
 
During the first 24 months of project implementation, multiple activities provided sustained 
prevention, treatment and recovery services. The outcomes of the consortium include an increase 
in collaboration, care providers focused on SUDs, and stigma reduction.  
 
Increase in Collaboration: Consortium membership increased in size and diversity – from four 
(4) organizations to fifteen (15), and a doubling membership of Recovery Community 
Organizations (RCOs). This resulted in expansion of services such as gas card support for 
treatment access, and funding the planning phase for a crisis nursery and a methadone clinic. 
Enhanced collaboration was evidenced throughout consortium activities. For example, 
community recovery event sponsorship increased from 10 in year one, to 30 community agencies 
in year two. 
 
Increase in Care Providers Addressing SUDs: Associated with our efforts, the number of 
Tooele County physicians to treat opioid use disorder with FDA-approved buprenorphine 
medication increased by 40% (from 5 to 7) during the first year of our project with a $200 
federally funded training stipend. Additionally, we created a database of 105 opioid prescribing 
providers, which will be used to promote controlled substance database (CSD) utilization and 
pain management training. When waiver training requirements shifted in 2021, an additional 
eight providers received MOUD training. 
 
Stigma Reduction: The consortium compiled a stigma reduction resource booklet for healthcare 
providers and community members, which includes evidence-based information on safe opioid 
use, prescribing guidelines, and treatment and harm reduction resources for people with 
SUD/OUD. Stigma reduction trainings were held at 11 community agencies and 1,100 resource 
guides have been distributed at 25 training and community events. 
 
Survey results from stigma reduction trainings showed increased support for MOUD (methadone 
and buprenorphine) and harm reduction interventions. Findings show there was a large increase 
in support from public attendees for harm reduction interventions. Table 1 shows the pre-post 
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Table 1. Changes in participants’ perception toward harm reduction methods after the training.  
Statement 





Methadone is a legitimate and effective medicine for treating opioid 
addiction. 
43% 90% 
Buprenorphine (often known by its brand names, “Suboxone” or 
“Subutex”) is a legitimate and effective medicine for treating opioid 
addiction. 
48% 90% 
Naloxone (often known by its brand name, “Narcan”), which is an 
opioid overdose reversal drug, is an effective medicine for preventing 
deaths due to opioid overdose.  
71% 100% 
I would be OK if Naloxone was distributed in my place of work. 71% 100% 
Harm reduction programs, such as syringe distribution programs and 
safe drug consumption facilities, help people who use drugs to begin 
to improve their health and can encourage such individuals to 
eventually engage in treatments like methadone and counseling. 
48% 100% 
 
Increase in Naloxone Access: We distributed 79 naloxone kits directly to community members 
and 660 naloxone kits to community agencies and consortium partners. We also surveyed local 
pharmacies and found that the majority of Tooele pharmacies carry naloxone and sell it without 
requiring a prescription. About half of pharmacy staff reported willingness to receive additional 
training on opioid overdose reversal.  
 
Public Value and Next Steps 
 
Our project created a space for Tooele County providers and community members to collaborate 
on building a recovery-ready community. Our efforts to date have resulted in identification of 
needs and gaps in services and preliminary efforts to address these gaps with evidence-based 
strategies for prevention, treatment, and recovery. Facilitated by our consortium, coordination 
and collaboration has resulted in improved access to, and availability of services for people with 
SUDs in Tooele County. These efforts are necessary in reducing the harms and mortality 
associated with SUDs.  
 
There is more to be done to address the needs of people with SUDs. We continue to develop our 
consortium’s capacity to collaborate with other relevant organizations on this persistent problem 
to serve more people. Stigma towards people with SUDs, by both the general public and health 
care providers, remains a substantial barrier. We continue to work to develop a professional 
workforce trained in harm reduction, and to create bridges to services for Tooele community 
members. Our current efforts include bringing new partners into our consortium, such as faith-
based organizations, criminal justice and law enforcement, and the local mental health authority. 
By building the capacity of local community organizations and institutions, the outcomes of this 
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